SARS and MERS: recent insights into emerging coronaviruses

de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology

Cited by (1,002)

Items 101–200 of 1,002

  1. An overview of COVID-19
    Yu Shi, Gang Wang, Xiao-peng Cai, Jing-wen Deng, Lin Zheng, Hai-Hong Zhu, Min Zheng, Bo Yang, Zhi Chen · 2020 · Journal of Zhejiang University SCIENCE B
  2. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
    Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, Julie M. Fox, Brittany K. Smith, Ian B. Harvey, Rita E. Chen, Emma S. Winkler, Alex W. Wessel, James Brett Case et al. · 2020 · Cell
  3. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study
    Dan Sun, Hui Li, Xiaoxia Lü, Xiao Han, Jie Ren, Fu-Rong Zhang, Zhisheng Liu · 2020 · World Journal of Pediatrics
  4. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency
    Thamina Acter, Nizam Uddin, Jagotamoy Das, Afroza Akhter, Tasrina Rabia Choudhury, Sunghwan Kim · 2020 · The Science of The Total Environment
  5. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
    Ren-Di Jiang, Mei-Qin Liu, Ying Chen, Chao Shan, Yi-Wu Zhou, Xu-Rui Shen, Qian Li, Lei Zhang, Yan Zhu, Hao-Rui Si et al. · 2020 · Cell
  6. Structural biology of SARS-CoV-2 and implications for therapeutic development
    Hai-Tao Yang, Z. Rao · 2021 · Nature Reviews Microbiology
  7. Aerosol transmission of SARS-CoV-2? Evidence, prevention and control
    Song Tang, Yixin Mao, Rachael M. Jones, Qiyue Tan, John S. Ji, Na Li, Jin Shen, Yuebin Lv, Lijun Pan, Pei Ding et al. · 2020 · Environment International
  8. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
    Junxiong Pang, Min Xian Wang, Ian Yi Han Ang, Sharon Hui Xuan Tan, Ruth Frances Lewis, Jacinta I‐Pei Chen, Ramona Alikiiteaga Gutiérrez, Sylvia Xiao Wei Gwee, Pearleen Ee Yong Chua, Qian Yang et al. · 2020 · Journal of Clinical Medicine
  9. Cytokine storm induced by SARS-CoV-2
    Peipei Song, Wei Li, Jianqin Xie, Yanlong Hou, Chongge You · 2020 · Clinica Chimica Acta
  10. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
    Lisa Miorin, Thomas Kehrer, María Teresa Sánchez-Aparicio, Ke Zhang, Phillip D. Cohen, Roosheel S. Patel, Anastasija Čupić, Tadashi Makio, Menghan Mei, Elena Moreno et al. · 2020 · Proceedings of the National Academy of Sciences
  11. Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
    Anh‐Tien Ton, Francesco Gentile, Michael Hsing, Fuqiang Ban, Artem R Cherkasov · 2020 · Molecular Informatics
  12. Age-Related Morbidity and Mortality among Patients with COVID-19
    Seung‐Ji Kang, Sook‐In Jung · 2020 · Infection and Chemotherapy
  13. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Andrea J. P. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinski, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell et al. · 2020 · Cell Reports
  14. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
    Ariane J. Brown, John J. Won, Rachel L. Graham, Kenneth H. Dinnon, Amy María Sims, Joy Y. Feng, Tomáš Cihlář, Mark R. Denison, Ralph Steven Baric, Timothy Patrick Sheahan · 2019 · Antiviral Research
  15. Public perception of the COVID-19 pandemic on Twitter: Sentiment analysis and topic modeling study
    Boon-Itt, Sakun, Skunkan, Yukolpat · 2020 · JMIR Public Health and Surveillance
  16. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
    Ong, Edison, Wong, Mei U, Huffman, Anthony, He, Yongqun · 2020 · Frontiers in Immunology
  17. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19
    Pascal Geldsetzer · 2020 · Journal of Medical Internet Research
  18. Organ-specific manifestations of COVID-19 infection
    Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Θεοδώρα Ψαλτοπούλου, Efstathios Kastritis, Evangelos Terpos, Meletios Athanasios Dimopoulos · 2020 · Clinical and Experimental Medicine
  19. Drug targets for corona virus: A systematic review
    Bikash Medhi, Manisha Prajapat#, Phulen Sarma#, Nishant Shekhar, Pramod Avti, Shweta Sinha, Hardeep Kaur, Subodh Kumar, Anusuya Bhattacharyya, Harish Kumar et al. · 2020 · Indian Journal of Pharmacology
  20. Forced Disruption of Anatomy Education in Australia and New Zealand: An Acute Response to the Covid‐19 Pandemic
    Nalini Pather, Phil Blyth, Jamie A. Chapman, Manisha Dayal, Natasha A.M.S. Flack, Quentin A. Fogg, Rodney A. Green, Anneliese K. Hulme, Ian Johnson, Amanda J. Meyer et al. · 2020 · Anatomical Sciences Education
  21. The many estimates of the COVID-19 case fatality rate
    Dimple Dayaram Rajgor, Meng Har Lee, Sophia Archuleta, Natasha Bagdasarian, Swee Chye Quek · 2020 · The Lancet Infectious Diseases
  22. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
    Kumari G. Lokugamage, Adam Hage, Maren de Vries, Ana M. Valero-Jimenez, Craig Schindewolf, Meike Dittmann, Ricardo Rajsbaum, Vineet D. Menachery · 2020 · Journal of Virology
  23. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19
    Jeong‐Min Kim, Yoon‐Seok Chung, Hye Jun Jo, Nam‐Joo Lee, Mi Seon Kim, SangHee Woo, Sehee Park, Jee Woong Kim, Heui Man Kim, Myung Guk Han · 2020 · Osong Public Health and Research Perspectives
  24. Coronavirus disease 2019 (COVID-19): a clinical update
    Min Zhou, Xinxin Zhang, Jieming Qu · 2020 · Frontiers of Medicine
  25. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
    Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay · 2020 · Frontiers in Immunology
  26. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
    Wioletta Rut, Zongyang Lv, Mikołaj Żmudziński, Stephanie Patchett, Digant Nayak, Scott J. Snipas, Farid El Oualid, Tony T. Huang, Miklós Békés, Marcin Drąg et al. · 2020 · Science Advances
  27. Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis
    Kirchdoerfer, Robert N., Wang, Nianshuang, Pallesen, Jesper, Wrapp, Daniel, Turner, Hannah L., Cottrell, Christopher A., Corbett, Kizzmekia S., Graham, Barney S., McLellan, Jason S., Ward, Andrew B. · 2018 · Scientific Reports
  28. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
    Ortiz-Prado, Esteban, Simbaña-Rivera, Katherine, Gómez- Barreno, Lenin, Rubio-Neira, Mario, Guaman, Linda P., Kyriakidis, Nikolaos C, Muslin, Claire, Jaramillo, Ana María Gómez, Barba-Ostria, Carlos, Cevallos-Robalino, Doménica et al. · 2020 · Diagnostic Microbiology and Infectious Disease
  29. Coronavirus disease 2019 (COVID-19) CT findings: A systematic review and meta-analysis
    Bao, Cuiping, Liu, Xuehuan, Zhang, Han, Li, Yiming, Liu, Jun · 2020 · Journal of the American College of Radiology
  30. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
    Su, Hai-xia, Yao, Sheng, Zhao, Wen-feng, Li, Min-jun, Liu, Jia, Shang, Wei-juan, Xie, Hang, Ke, Chang-qiang, Hu, Hang-chen, Gao, Mei-na et al. · 2020 · Acta Pharmacologica Sinica
  31. Interplay between SARS-CoV-2 and the type I interferon response
    Sa Ribero, Margarida, Jouvenet, Nolwenn, Dreux, Marlène, Nisole, Sébastien · 2020 · PLOS Pathogens
  32. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
    Wolfgang Miesbach, Michael Makris · 2020 · Clinical and Applied Thrombosis/Hemostasis
  33. COVID-19 and multiorgan failure: A narrative review on potential mechanisms
    Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, Babak Ebrahimi, Atousa Yarahmadi, Ghomareza Hassanzadeh · 2020 · Journal of Molecular Histology
  34. Emerging and re-emerging coronaviruses in pigs
    Qiuhong Wang, Anastasia Nickolaevna Vlasova, Scott P. Kenney, Linda J. Saif · 2019 · Current Opinion in Virology
  35. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
    Xiao, Wenjing, Jiang, Wenjie, Chen, Zheng, Huang, Yu, Mao, Junyi, Zheng, Wei, Hu, Yonghe, Shi, Jianyou · 2025 · Signal Transduction and Targeted Therapy
  36. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
    Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu Erica Lee, Pauline R. Hoffman, Susan Ker-hwa Ou, Leesa M. Kakutani, Jennifer R. Keeffe, Hung‐Jen Wu, Mark R. Howarth, Anthony P. West et al. · 2021 · Science
  37. Antiviral activities of flavonoids
    Syed Lal Badshah, Shah Faisal, Akhtar Muhammad, Benjamin Gabriel Poulson, Abdul Hamid Emwas, Mariusz Jaremko · 2021 · Biomedicine & Pharmacotherapy
  38. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
    Maryam Edalatifard, Maryam Akhtari, Mohammadreza Salehi, Zohre Naderi, Ahmadreza Jamshidi, Shayan Mostafaei, Seyed Reza Najafizadeh, Elham Farhadi, Nooshin Jalili, Masoud Esfahani et al. · 2020 · European Respiratory Journal
  39. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway
    Shahanshah Khan, Mahnoush S. Shafiei, Christopher Longoria, John Schoggins, Rashmin C. Savani, Hasan Zaki · 2021 · eLife
  40. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
    Qiang Ding, Panpan Lu, Yuhui Fan, Yujia Xia, Mei Liu · 2020 · Journal of Medical Virology
  41. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
    Sabina A. Guler, Lukas Ebner, Catherine Beigelman‐Aubry, Pierre‐Olivier Bridevaux, Martin Hugo Brutsche, Christian Friedrich Clarenbach, Christian Garzoni, Thomas Geiser, Alexandra Lenoir, Marco Mancinetti et al. · 2021 · European Respiratory Journal
  42. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
    Bassetti, Matteo, Vena, Antonio, Giacobbe, Daniele Roberto · 2020 · European Journal of Clinical Investigation
  43. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
    Leo Swadling, Mariana O. Diniz, Nathalie M. Schmidt, Oliver E. Amin, Aneesh Chandran, Emily Shaw, Corinna Pade, Joseph M. Gibbons, Nina Le Bert, Anthony Tanoto Tan et al. · 2021 · Nature
  44. Type III interferons disrupt the lung epithelial barrier upon viral recognition
    Achille Broggi, Sreya Ghosh, Benedetta Sposito, Roberto Spreafico, Fabio Balzarini, Antonino Lo Cascio, Nicola Clementi, Maria De Santis, Nicasio Mancini, Francesca Granucci et al. · 2020 · Science
  45. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
    Yuefei Jin, Wangquan Ji, Haiyan Yang, Shuaiyin Chen, Weiguo Zhang, Guangcai Duan · 2020 · Signal Transduction and Targeted Therapy
  46. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
    Davey L. Jones, Marcos Quintela‐Baluja, David W. Graham, Alexander Corbishley, James E. McDonald, Shelagh K. Malham, Luke S. Hillary, Thomas R. Connor, William H. Gaze, Inês Barata Moura et al. · 2020 · The Science of The Total Environment
  47. Pathophysiological mechanisms of liver injury in COVID‐19
    Alexander Daniel Nardo, Mathias Schneeweiss‐Gleixner, May Bakail, Emmanuel Dauda Dixon, Sigurd Lax, Michael Trauner · 2020 · Liver International
  48. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
    David Ezra Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Matthew J. O’Meara, Jeffrey Z. Guo, Danielle L. Swaney, Tia A. Tummino, Ruth Hüttenhain et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Saliva: potential diagnostic value and transmission of 2019-nCoV
    Ruoshi Xu, Bomiao Cui, Xiaobo Duan, Ping Zhang, Xuedong Zhou, Quan Yuan · 2020 · International Journal of Oral Science
  50. Immunological and inflammatory profiles in mild and severe cases of COVID-19
    Jin‐Wen Song, Chao Zhang, Xing Fan, Fan-Ping Meng, Zhe Xu, Peng Xia, Wen-Jing Cao, Tao Yang, Xiao-Peng Dai, Siyu Wang et al. · 2020 · Nature Communications
  51. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
    Franck Touret, Magali Gilles, Karine Barral, Antoine Nougaırède, Jacques van Helden, Étienne Decroly, Xavier Nicolas de Lamballerie, Bruno Coutard · 2020 · Scientific Reports
  52. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
    Xufang Deng, Matthew Hackbart, Robert C. Mettelman, Amornrat O’Brien, Anna M. Mielech, Guanghui Yi, C. Cheng Kao, Susan C. Baker · 2017 · Proceedings of the National Academy of Sciences
  53. Neurobiology of COVID-19
    Majid Fotuhi, Ali Mian, Somayeh Meysami, Cyrus A. Raji · 2020 · Journal of Alzheimer s Disease
  54. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
    Didier Raoult, Alimuddin I. Zumla, Franco Locatelli, Giuseppe Ippolito, Guido Kroemer · 2020 · Cell Stress
  55. Covid‐19 vaccines and variants of concern: A review
    Ikbel Hadj Hassine · 2021 · Reviews in Medical Virology
  56. Nanotechnology for COVID-19: Therapeutics and Vaccine Research
    Gaurav Chauhan, Marc Jozef Madou, Sourav Kalra, Vianni Chopra, Deepa Ghosh, Sergio Omar Martinez-Chapa · 2020 · ACS Nano
  57. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
    Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang · 2022 · Nature reviews. Immunology
  58. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
    Mark Peter Lythgoe, Paul K. Middleton · 2020 · Trends in Pharmacological Sciences
  59. Medical Students and COVID-19: Knowledge, Attitudes, and Precautionary Measures. A Descriptive Study From Jordan
    Ashraf I. Khasawneh, Anas H. A. Abu-Humaidan, Jomana Alsulaiman, Sarah Bloukh, Mohannad Ramadan, Tariq N. Al‐Shatanawi, Hasan H. Awad, Waleed Y. Hijazi, Kinda R. Al-Kammash, Nail A. Obeidat et al. · 2020 · Frontiers in Public Health
  60. Large-scale screening to distinguish between COVID-19 and community-acquired pneumonia using infection size-aware classification
    Feng Shi, Liming Xia, Fei Shan, Bin Song, Dijia Wu, Ying Wei, Huan Yuan, Huiting Jiang, Yichu He, Yaozong Gao et al. · 2021 · Physics in Medicine and Biology
  61. Novel Insights Into Immune Systems of Bats
    Arinjay Banerjee, Michelle L. Baker, Kirsten A. Kulcsar, Vikram Misra, Raina K. Plowright, Karen Louise Mossman · 2020 · Frontiers in Immunology
  62. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
    Antonella Francesca Fara, Zan K. Mitrev, Rodney Alexander Rosalia, Mushref Bakri Assas · 2020 · Open Biology
  63. AI-Driven Tools for Coronavirus Outbreak: Need of Active Learning and Cross-Population Train/Test Models on Multitudinal/Multimodal Data
    Santosh, K. C. · 2020 · Journal of Medical Systems
  64. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
    Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione · 2020 · Journal of Global Antimicrobial Resistance
  65. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
    Brian J. Ward, Philipe Gobeil, Annie Séguin, Judith Atkins, Iohann Boulay, Pierre-Yves Charbonneau, Manon Couture, Marc‐André D’Aoust, Jiwanjeet K. Dhaliwall, Carolyn D. Finkle et al. · 2021 · Nature Medicine
  66. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases
    Shikha Jain, Monika Nehra, Rajesh Kumar, Neeraj Dilbaghi, Ye Hu, Sandeep Kumar, Ajeet Kumar Kaushik, Chen-Zhong Li · 2021 · Biosensors and Bioelectronics
  67. Effective inhibition of MERS-CoV infection by resveratrol
    Shih‐Chao Lin, Chi‐Tang Ho, Wen‐Ho Chuo, Shiming Li, Tony T. Wang, Chi‐Chen Lin · 2017 · BMC Infectious Diseases
  68. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
    Schäfer, Alexandra, Muecksch, Frauke, Lorenzi, Julio C.C., Leist, Sarah R., Cipolla, Melissa, Bournazos, Stylianos, Schmidt, Fabian, Maison, Rachel M., Gazumyan, Anna, Martinez, David R. et al. · 2021 · Journal of Experimental Medicine
  69. A candidate multi-epitope vaccine against SARS-CoV-2
    Tamalika Kar, Utkarsh Narsaria, Srijita Basak, Debashrito Deb, Filippo Castiglione, David M. Mueller, Anurag Prakash Srivastava · 2020 · Scientific Reports
  70. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation
    Zhihua Bai, Ying Cao, Wen-Jun Liu, Jing Li · 2021 · Viruses
  71. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
    Atyeo, Caroline, Fischinger, Stephanie, Zohar, Tomer, Slein, Matthew D., Burke, John, Loos, Carolin, McCulloch, Denise J., Newman, Kira L., Wolf, Caitlin, Yu, Jingyou et al. · 2020 · Immunity
  72. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
    Bhupesh Goyal, Deepti Goyal · 2020 · ACS Combinatorial Science
  73. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
    Kris M. White, Romel Rosales, Soner Yildiz, Thomas Kehrer, Lisa Miorin, Elena Moreno, Sonia Jangra, Melissa B. Uccellini, Raveen Rathnasinghe, Lynda Coughlan et al. · 2021 · Science
  74. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
    Vijay Kumar Bhardwaj, Rahul Singh, Jatin Sharma, Vidya Rajendran, Rituraj Purohit, Sanjay Kumar · 2020 · Journal of Biomolecular Structure and Dynamics
  75. Pathophysiology of COVID-19: Why Children Fare Better than Adults?
    Nitin Dhochak, Tanu Singhal, Sushil Kumar Kabra, Rakesh Lodha · 2020 · The Indian Journal of Pediatrics
  76. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
    Yanwen Liang, Mong‐Lien Wang, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ping Yang, Wei-Yi Lai, Yung‐Hung Luo, Yi-Tsung Lin, Yann-Jang Chen, Pei‐Ching Chang et al. · 2020 · Frontiers in Immunology
  77. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach
    Salman Ali Khan, Komal Zia, Sajda Ashraf, Reaz Uddin, Zaheer Ul‐Haq · 2020 · Journal of Biomolecular Structure and Dynamics
  78. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis
    Hong Shu Liu, Shiyan Chen, Min Liu, Hao Nie, Hongyun Lu · 2020 · Aging and Disease
  79. Immune-mediated approaches against COVID-19
    Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, Rita C. Acúrcio, Bárbara Carreira, Eilam Yeini, Galia Tiram, Yulia Liubomirski, Ronit Satchi‐Fainaro · 2020 · Nature Nanotechnology
  80. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
    S. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, Victoria Stalls, Megan Kopp, Rory C. Henderson, Robert J. Edwards et al. · 2020 · Cell Reports
  81. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
    Dounia Darif, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, Khadija Akarid · 2021 · Microbial Pathogenesis
  82. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
    Jiang, He-wei, Li, Yang, Zhang, Hai-nan, Wang, Wei, Yang, Xiao, Qi, Huan, Li, Hua, Men, Dong, Zhou, Jie, Tao, Sheng-ce · 2020 · Nature Communications
  83. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.
    Shen, Liang, Niu, Junwei, Wang, Chunhua, Huang, Baoying, Wang, Wenling, Zhu, Na, Deng, Yao, Wang, Huijuan, Ye, Fei, Cen, Shan et al. · 2019 · Journal of Virology
  84. Going Virtual to Support Anatomy Education: A STOPGAP in the Midst of the Covid‐19 Pandemic
    Darrell J. R. Evans, Boon‐Huat Bay, Timothy D. Wilson, Claire France Smith, Nirusha Lachman, Wojciech Pawlina · 2020 · Anatomical Sciences Education
  85. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics
    Zhichao Feng, Qizhi Yu, Shanhu Yao, Lei Luo, Wenming Zhou, Xiaowen Mao, Jennifer S.Y. Li, Junhong Duan, Zhimin Yan, Min Hee Yang et al. · 2020 · Nature Communications
  86. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
    Nicholas C. Huston, Han Wan, Madison S. Strine, Rafael de Cesaris Araujo Tavares, Craig B. Wilen, Anna Marie Pyle · 2021 · Molecular Cell
  87. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2
    Yun Hee Baek, Jihye Um, Khristine Joy C. Antigua, Ji Hyun Park, Yeonjae Kim, Sol Oh, Young‐Il Kim, Won-Suk Choi, Seong Gyu Kim, Ju Hwan Jeong et al. · 2020 · Emerging Microbes & Infections
  88. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
    Nikhil Kirtipal, Shiv Bharadwaj, Sang Gu Kang · 2020 · Infection Genetics and Evolution
  89. Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility
    Wentao Li, Ruben J. G. Hulswit, Scott P. Kenney, Ivy Widjaja, Kwonil Jung, Moyasar A. Alhamo, Brenda van Dieren, Frank J. M. van Kuppeveld, Linda J. Saif, Berend‐Jan Bosch · 2018 · Proceedings of the National Academy of Sciences
  90. Overview of lethal human coronaviruses
    Bin Chen, Er-Kang Tian, Bin He, Lejin Tian, Ruiying Han, Shuangwen Wang, Qianrong Xiang, Shu Zhang, Toufic El Arnaout, Wei Cheng · 2020 · Signal Transduction and Targeted Therapy
  91. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
    Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, Mettu Srinivas Reddy, Mohamed Rela · 2020 · Inflammopharmacology
  92. Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures
    Seth David Judson, Vincent Jacobus Munster · 2019 · Viruses
  93. The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
    Lo’ai Alanagreh, Foad Alzoughool, Manar Fayiz Mousa Atoum · 2020 · Pathogens
  94. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes
    Ravindra, Neal G., Alfajaro, Mia Madel, Gasque, Victor, Huston, Nicholas C., Wan, Han, Szigeti-Buck, Klara, Yasumoto, Yuki, Greaney, Allison M., Habet, Victoria, Chow, Ryan D. et al. · 2021 · PLOS Biology
  95. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
    Lea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, Aneesh Thakur · 2020 · Frontiers in Immunology
  96. Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
    Shuai Wang, Tong Dai, Ziran Qin, Ting Shuang Pan, Feng Chu, Lingfeng Lou, Long Zhang, Bing Yang, Huizhe Huang, Huasong Lu et al. · 2021 · Nature Cell Biology
  97. Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements
    Ilaria Manfredonia, Chandran Nithin, Almudena Ponce-Salvatierra, Pritha Ghosh, Tomasz K. Wirecki, Tycho Marinus, Natacha S. Ogando, Eric J. Snijder, Martijn J. van Hemert, Janusz Marek Bujnicki et al. · 2020 · Nucleic Acids Research
  98. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
    Liguo Zhang, Alexsia L. Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, Rudolf Jaenisch · 2021 · Proceedings of the National Academy of Sciences
  99. COVID-19, una emergencia de salud pública mundial
    Mariali Palacios-Cruz, Edgar Santos, M.A. Velázquez Cervantes, Moisés León‐Juárez · 2020 · Revista Clínica Española
  100. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
    Kajal Rawat, Puja Kumari, Lekha Saha · 2020 · European Journal of Pharmacology